Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Shares of Credicorp are down 0.75% at $377.01. The company is worth $29.94B, number 444 out of 800 on our list.
Over the past 52 weeks it has traded between $219.94 and $413.25, so it sits 8.8% below the top of that range.
Revenue for the quarter ended Jun 2026 was PEN 6.86B, up 12.3% from a year earlier, with PEN 2.03B of net profit (a 28.8% margin).
The stock changes hands at 14.0 times trailing earnings, 27% above its five-year average of 11.0.
4 analysts follow the stock and the average call is "buy". The mean target, $455.50, sits 20.8% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 4 factors below, ranked against the 800 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Higher trailing yield than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
4 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
BAP is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-07-06, the strategy has returned 1524.8% (321.7% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $455.50, 20.8% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $338.83, so shares trade 11.3% above that estimate. On earnings multiple, it sits in the 90th percentile of its own five-year valuation range (pricier than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 1, 2026 12:30 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 800 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
$377.01 is the latest print for BAP, a move of -0.75% against yesterday's close of $379.87. Today's low and high so far: $373.45 and $380.86.
Equity value comes to $29.94B at the current price. By that measure it is number 444 of the 800 names in our coverage.
Buyers pay 14.0 times the last twelve months of profit (EPS $25.29). Averaged over five years the multiple has been 11.0, and today's level ranks in the 90th percentile of its own history.
The year's floor is $219.94 and the ceiling $413.25. Shares are 8.8% away from that ceiling.
It does. Payouts over the past twelve months work out to a 3.89% yield; the latest ex-dividend date was May 18, 2026.
Of 4 analysts, 75% say buy, 25% hold and 0% sell. Price targets average $455.50, with the most cautious at $399.00 and the most optimistic at $483.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on BAP.